Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience

BACKGROUND: Cefiderocol is a novel siderophore cephalosporin with promising activity against most carbapenem-resistant Gram-negative bacteria (CRGNB). However, extensive postmarketing experiences are lacking. This study aimed to analyse the early experience on cefiderocol postmarketing use at three...

Descripción completa

Detalles Bibliográficos
Autores principales: Piccica, Matteo, Spinicci, Michele, Botta, Annarita, Bianco, Vincenzo, Lagi, Filippo, Graziani, Lucia, Faragona, Alessandro, Parrella, Roberto, Giani, Tommaso, Bartolini, Andrea, Morroni, Gianluca, Bernardo, Mariano, Rossolini, Gian Maria, Tavio, Marcello, Giacometti, Andrea, Bartoloni, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631827/
https://www.ncbi.nlm.nih.gov/pubmed/37807834
http://dx.doi.org/10.1093/jac/dkad298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631827/
https://www.ncbi.nlm.nih.gov/pubmed/37807834
http://dx.doi.org/10.1093/jac/dkad298

Ejemplares similares